07:00 , Oct 13, 2016 |  BC Innovations  |  Product R&D

Elastic bones

A group at Northwestern University has created a "hyperelastic bone" scaffold to address the need for a bone-inducing material that is easily manufactured, low cost and easy to manipulate during surgery. While the short-term goal...
07:00 , Jun 27, 2016 |  BC Week In Review  |  Company News

UCLA, Bone Biologics deal

UCLA granted Bone Biologics an option to license exclusive, worldwide rights to use NEL-like protein 1 (NELL1) to treat osteoporosis. Bone Biologics is funding development of a NELL1-based product to treat bone regeneration in spinal...
08:00 , Mar 7, 2016 |  BC Week In Review  |  Financial News

Bone Biologics completes private placement of convertible notes

Bone Biologics Corp. (OTCQB:BBLG), Edison, N.J.   Business: Musculoskeletal   Date completed: 2016-02-29   Type: Private placement of convertible notes   Raised: $2 million   Shares outstanding prior: 33.3 million   Investor: Hankey Capital  ...
08:00 , Mar 7, 2016 |  BC Week In Review  |  Financial News

Bone Biologics completes private placement

Bone Biologics Corp. (OTCQB:BBLG), Edison, N.J.   Business: Musculoskeletal   Date completed: 2016-02-29   Type: Private placement   Raised: $2.5 million   Shares: 1.2 million   Price: $2.05   Shares after offering: 33.3 million  ...
07:00 , May 11, 2015 |  BC Week In Review  |  Financial News

Bone Biologics completes venture financing

Bone Biologics Corp. , Edison, N.J.   Business: Musculoskeletal   Date completed: 2015-05-04   Type: Venture financing   Raised: $2 million   Investor: Hankey Capital   Note: The convertible note matures on May 4, 2018,...
08:00 , Nov 24, 2014 |  BC Week In Review  |  Company News

Bone Biologics management update

Bone Biologics Corp. , Edison, N.J.   Business: Musculoskeletal   Hired: Deina Walsh as CFO  ...
07:00 , Mar 15, 2010 |  BC Week In Review  |  Company News

Bone Biologics board of directors update

Bone Biologics Inc. , Thousand Oaks, Calif.   Business: Musculoskeletal   Appointed: Mark Spilker, VP of R&D at the Musculoskeletal Transplant Foundation  ...
07:00 , Mar 15, 2010 |  BC Week In Review  |  Financial News

Bone Biologics completes venture financing

Bone Biologics Inc. , Thousand Oaks, Calif.   Business: Musculoskeletal   Date completed: 3/10/10   Type: Venture financing   Raised: Undisclosed   Investor: Musculoskeletal Transplant Foundation   Note: The investor also provided an undisclosed line...
08:00 , Mar 2, 2009 |  BC Week In Review  |  Clinical News

Bone Biologics preclinical data

Data from a primate model of spinal bone fusion surgery showed that Bone Biologics' UCB-1 combined with DBX demineralized bone matrix produced a 100% fusion rate at 3 months without cystic lesions and ectopic bone...